Hawryluk P. Kent 13D/13G Filings for MBX Biosciences, Inc. Common Stock (MBX)

Hawryluk P. Kent 13D and 13G filings for MBX Biosciences, Inc. Common Stock:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-11-14
4:05 pm
Purchase
2025-09-3013GMBX Biosciences, Inc. Common Stock
MBX
Hawryluk P. Kent1,995,759
4.300%
1,995,759increase
(New Position)
Filing